|
|
|
|
||
Re: This amyloidosis looks like $750 mil run rate for last year $1b plus for this year no reason why GSK can't trade to $45 I've been in LLY for several years when their pipeline was mediocre- huge turn there -- look at the Elanco deal I think we'll see the same here |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
60439 | Re: This amyloidosis | ayla5668 | 0 | 1/15/2019 9:47:12 AM |